Biotech Rivals Settle Suit Over Cancer Research Yeast

Law360, New York (October 12, 2005, 12:00 AM EDT) -- Cypress Systems Inc. will hand over its customer list to rival Biothera and concede that its rival’s patents for a yeast used in cancer research are valid, as part of a settlement between the two companies.

The deal settles a lawsuit filed by Biothera against California-based Cypress in March in U.S. District Court for the District of Minnesota.

Biothera had alleged infringement of its patents for beta glucan, a yeast commonly used in dietary supplements and now gaining popularity as a cancer research tool.

Under the...
To view the full article, register now.